Boston Scientific leads the pulsed field ablation (PFA) technology market to treat atrial fibrillation (Afib). But it is by no means alone in its commitment to this relatively new way to treat some ...

A major international trial has found that pulsed-field catheter ablation offers superior outcomes to antiarrhythmic drugs for patients with persistent atrial fibrillation. One year after treatment, ...

Augusta Health now offers the Abbott Volt Pulsed Field Ablation System as a safer option for treating AFib patients.

Pulsed field ablation did not have superior efficacy to radiofrequency ablation in patients with drug-resistant paroxysmal (intermittent) atrial fibrillation, according to results from a late-breaking ...

It is expected that within the next 20 years that 20 million-60 million people will get atrial fibrillation, usually just called AFib. People with AFib have a five-times increased risk of stroke ...

Pulsed field ablation allows us to treat AFib in a way that is minimally invasive, efficient and designed to enhance both safety and recovery.” — Dr. Saumil Oza ...

Kardium has collected an FDA approval for its pulsed field ablation approach to treating atrial fibrillation, giving it the go-ahead to compete in the emerging sector against heavyweights such as ...

First-line treatment with pulsed field ablation (PFA) reduced the risk of recurrence of atrial arrhythmia among patients with persistent atrial fibrillation (Afib), the randomized AVANT GUARD trial ...